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This newsletter was jointly developed and 
subject to editorial review by Jefferson 
School of Population Health and Lilly 
USA, LLC, and is supported through 
funding by Lilly USA, LLC. The content 
and viewpoints expressed are those of the 
individual authors, and are not necessarily 
those of Lilly USA, LLC or the Jefferson 
School of Population Health.
Last summer marked the 6-year 
anniversary of our partnership with Eli 
Lilly and Company to bring you our 
collaborative newsletter, Prescriptions for 
Excellence in Health Care (PEHC). This 
issue is the first in a series devoted to an 
extremely important but often overlooked 
and underappreciated element in the 
process of transforming US health care 
– the critical role of hospital boards in 
ensuring the quality of care. 
Before 2000, quality and safety were largely 
missing from hospital board agendas, if 
they were discussed at all. With the nation’s 
slow but steady push toward transparency 
and accountability in health care, things 
are beginning to change for the better at 
the governing board level. However, we 
still have a long way to go to understand 
how the definition of quality has changed 
in this new era of accountable, integrated 
care (ie, identifying the short- and long-
term implications for board responsibility, 
determining how best to design and deliver 
appropriate training for board members). 
If you are at all skeptical about the 
importance of the topic, consider this. 
Currently, the boards of over 5000 
community hospitals in this country 
are populated largely by businesspeople 
(eg, the local car dealer), philanthropists, 
religious leaders, and local politicians. All 
of them make a huge time commitment, 
most serve without pay, and - whether 
they fully realize it or not - all are at 
personal risk for fulfilling the fiduciary 
responsibilities of their organizations. 
With the advent of pay for performance, 
hospitals are now at financial risk if 
they fail to meet specific quality metrics 
around “never” events (eg, wrong site 
surgery, readmission for heart failure 
within 30 days of discharge). Good 
governance dictates that clinicians 
cannot be held solely responsible for 
a hospital’s quality and safety record. 
Counterintuitive as it may seem, the 
nonclinical members of the governing 
board bear responsibility for the hospital’s 
clinical outcomes. That being said, we 
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determined that the timing was right 
for an in-depth discussion.
We set the stage for the series with 
a high-level overview of governance, 
“The Future of Board Governance: 
The Board as a Mosaic of Talent,” an 
engaging account of where we’ve been 
and where we’re going from a “30,000-
foot” perspective. 
The second article, “The Board’s 
Role in Quality and Patient Safety,” 
offers a comprehensive summary 
that explains the rationale for board 
involvement, discusses the evolving 
definition of quality, and hones in on 
the various levers, tactics, and tasks for 
ensuring success. Next, we drill down 
a little further into some essential 
elements for good governance in an 
aptly titled article, “The Journey to 
Better Governance: Board Education, 
Competencies, and Self-Assessment.”
With the Affordable Care Act firmly 
in place and the Accountable Care 
Organization (ACO) model gaining 
traction, the final article, “Pioneering at 
the Trust Frontier: The Expanded Role 
of Governance in ACOs,” takes a look at 
the complexities of multiorganization 
boards and the additional oversight 
challenges they pose. 
To date, there are no “how-to” 
textbooks or programs that cover this 
topic. However, an organization called 
The Governance Institute (www.
governanceinstitute.com) has developed 
a variety of resources and tools to help 
equip boards for success. Among their 
offerings are regular regional leadership 
conferences. The complete schedule of 
programs is available on their Web site 
at http://www.governanceinstitute.com/
Conferences/ConferenceCalendar/
tabid/79/Default.aspx. On February 
10, 2013, I will be coleading a 
preconference education session at the 
Governance Institute’s Winter Meeting 
in Palm Beach, Florida, and encourage 
interested readers to attend. 
As always, I look forward to hearing 
from our readers. I can be reached at: 
david.nash@jefferson.edu.
Over the past 3 decades, the public 
company board of directors has evolved 
from a board composed of friends, family, 
and social and business acquaintances 
of the chief executive officer (CEO) to 
a board now dominated by independent 
members who have no unduly close ties 
to the top management of the company. 
It is a board that has gone from being 
what is derogatorily referred to as an 
“old boys’ club” to a board that is a being 
remolded to be a “mosaic of talent”: 
each member selected for a specific 
background or skill set that he or she can 
bring to complement the overall mix of 
expertise sitting around the board table. 
This review provides a basis for 
projecting how the future of board 
governance, specifically in terms of 
board composition, will continue to 
unfold. To the extent that there is a 
“spillover effect” of corporate practices 
being adopted into the not-for-
profit sector — a trend recognized by 
Jefferson School of Population Health 
Dean David B. Nash in his coauthored 
(with Sean Patrick Murphy and Anne 
D. Mullaney) article, “Governance: 
Current Trends in Board Education, 
Competencies, and Qualifications”1 
— the forces that caused a rethinking 
and remaking of public company 
board membership are worthy of close 
attention by leaders of private and not-
for-profit health care institutions. To see 
how this evolution has played out, here 
are a few key milestones of change.
The 1970s  
The Securities and Exchange 
Commission began a bully-pulpit 
campaign for a more independent 
board. An ideal board, in its view, 
would be one composed entirely 
of independent directors, with the 
chairman and CEO roles separated. 
Other developments at work: 
•  Nominating committees were 
being formed as a separate and 
distinct formal board committee. 
General Motors (GM) had one 
of the first when it established its 
committee in 1972. 
•  Women began to enter the 
boardroom in growing numbers. 
Pfizer, for example, added the first 
woman to the board in 1976.
•  The stock exchanges began to take 
the concept of an independent 
board more seriously. In fact, 
the New York Stock Exchange 
threatened to delist Johnson & 
Johnson in 1978 unless it added 
the first independent directors to 
its board.
The Future of Board Governance: The Board as a Mosaic of Talent
By James Kristie
3Prescriptions for Excellence in Health Care
This newsletter was jointly developed and subject to editorial review by Jefferson School of Population Health and Lilly USA, LLC, and is supported through funding by Lilly USA, LLC. 
(continued on page 4)
The 1980s  
Building on this initial momentum 
for a less management-dominated 
and insider-populated board, these 3 
developments advanced that evolution:
1.  Corporate takeovers: With many 
companies still operating as 
conglomerates of unrelated 
businesses, their stock prices 
often sold at far below breakup 
calculations. Raiders such as T. 
Boone Pickens and Carl Icahn 
took notice and began preying 
on such “mispriced” companies. 
Shareholders started paying 
attention to how boards handled 
the transactional deal making.
2.  Activist courts: Precedent-setting 
decisions, frequently an outcome of 
bungled Merger and Acquisition 
behavior by boards, were issued by 
the influential Delaware Chancery 
and Supreme Courts, pointing to the 
need for directors to be much more 
diligent about their fiduciary duties.
3.  Rise of the institutional investor:  
With the big bull market that started 
in 1982 and the huge inflows of 
funds into new retirement vehicles 
such as individual retirement 
accounts, institutional investors 
began owning larger percentages 
of company stock. Proxy voting 
became a tool for shareholders 
to more aggressively assert their 
ownership rights when unhappy 
with management and the board. 
The 1990s  
As we entered the 1990s, shareholders 
were more vocal and had more muscle 
to push back on boards, as did boards 
on management. What happened then?
•  When corporate performance faltered, 
boards were less willing to sit idly by: 
A bevy of CEOs began to get the 
boot. In 1 year alone (1993) the 
CEOs of IBM, American Express, 
Westinghouse Electric, and 
Kodak all were fired by “suddenly 
emboldened” boards.
•  Boards formally codified their roles 
and responsibilities: This move 
was inspired by the board of GM, 
which in 1994 issued a set of 28 
governance principles that laid out 
for all the world to see how the 
GM board would conduct itself 
—from determining the board 
meeting agenda to how it would 
select new board members.
•  Rise of the lead director: A new 
position began appearing in 
boardrooms — a single member 
designated to be the leader of the 
independent directors on boards 
that lacked a separation of the chair 
and CEO.
The 2000s 
Two historic pieces of legislation further 
solidified the professionalism of boards: 
•  Despite having a highly credentialed 
board, the Houston-based energy 
company Enron collapsed almost 
overnight into bankruptcy in 2001, 
and the next year Congress unleashed 
Sarbanes-Oxley. The law mandated 
that a board have a “financial expert” 
among its members, an important 
precedent highlighting the need for a 
specific skill set on the board. 
•  The Great Recession provoked  
the Dodd-Frank Act, signed  
into law in 2010. One provision, 
again pertinent to this analysis, 
is that boards now must codify 
their policy on board diversity and 
enumerate the qualifications of 
their board members.
What the Future Holds 
Looking to the future after this 30-
year sequence of initiatives for boards 
to become more independent, the big 
issue is, “How can boards get smarter 
about the organizations they govern?” 
In recruiting a new director, the 
prevailing marching order no longer is 
to “get the best person available.” That 
was how it was done when I entered 
the field 30 years ago. Today, boards 
follow a different script: “What’s 
missing on our board . . . and let’s find 
the right person to fill that gap.” 
So what recruiting trends can we 
expect to see that will make boards 
more knowledgeable and skilled 
overseers of their organizations? Here 
are 5 prime trends:
1.  Fewer CEOs, more senior executives: 
For decades, getting a “sitting 
CEO” has been the gold standard 
for a new board member. But 
CEOs, fearing the liability and 
time commitment required, are 
cutting back dramatically on the 
number of outside corporate boards 
they will take on. Plus, their own 
company boards are restricting 
them from outside board service. 
Up-and-coming senior officers are 
prime candidates. This is seen as 
a career-enhancing step for them, 
so the expectation is that they will 
be more diligent in taking their 
oversight role seriously.
2.  Greater gender diversity: Women 
represent about 16% of the 
membership of Fortune 500 boards, 
a number that has not moved 
much in a decade. With board 
quotas catching on in Europe, 
there is a “gathering storm” of 
women’s organizations here in the 
United States pushing for greater 
participation of women on boards. 
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Fueling the movement is a growing 
body of literature that links higher 
performance of companies with 
greater representation of women on 
their boards.2 
3.  Age diversity: With 62 as the average 
age of a corporate director, attention 
is being focused on the “graying” of 
corporate boards as a governance 
weakness.3 Expect to see a younger 
cohort advance into the boardroom 
to reflect the information age and 
the rapidity of technological change.
4.  The “social” director: In 2011, 
Starbucks Corp. added to its board 
a 29-year-old CEO of a social 
media company. That action riveted 
attention in the governance world. 
One top recruiting firm confided 
that as of April 2012 it had 40 open 
searches under way for directors 
with social media expertise. 
5.  Other in-demand skill sets:  
Desired directors will include: 
senior human resource officers 
to help boards with talent 
management and compensation 
oversight issues; health care 
executives to help boards with 
health care delivery and cost 
management issues; and executives 
with legal backgrounds, such as 
retired general counsels, to help 
boards meet their expanding 
compliance responsibilities.
The Mosaic of Talent 
This set of broad brushstrokes 
shows how corporate boards have 
professionalized their membership over 
the past 30 years, moving decisively 
from a “who’s available?” to a “who 
do we need?” imperative in recruiting 
new members. Corporate America 
has gone from a look-alike, think-
alike board to a board as a mosaic of 
individuals with diverse but additive 
expertise, strengths, personalities, and 
backgrounds as well as ages and sexes. 
Some of these forces have already, 
or may yet, exert themselves in the 
remaking of health care institution 
boards for an era of profound changes 
to their missions and businesses. 
James Kristie is editor and associate 
publisher of Directors & Boards, a 
quarterly journal devoted to corporate 
governance. He can be reached at: 
jkristie@directorsandboards.com 
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Governing boards have come a long 
way in comprehending and accepting 
their roles in and responsibilities for 
quality and patient safety. In addition 
to grasping and navigating the 
organization’s financial health, boards 
now realize that it is necessary to 
comprehend the quality of health care 
delivered by their organizations. 
Over the past decade, progress made 
in the science of improvement, and 
increased national attention on 
improving population health, have 
created the imperative for boards to not 
only comprehend quality and safety but 
also to focus attention on the important 
work of improving value for their 
patients. Governing boards must have 
in-depth knowledge of the challenges 
of providing reliable care, the role of 
systems in health care settings, the 
existing waste and redundancy in health 
care systems that may lead to significant 
geographic variation in health care costs, 
and the significant amount of harm that 
still is produced within the health care 
environment today.
A Bit of History 
To better appreciate the needs of 
governing bodies, it is important to 
understand the history of governing 
boards of health care organizations.
In 1965, a landmark legal decision 
in the case of Darling vs. Charleston 
Community Memorial Hospital 
placed the ultimate responsibility for 
the quality of patient care with the 
governing board of the hospital. In this 
case, an Illinois star athlete’s broken leg 
was set improperly by a physician at 
the hospital, and the landmark decision 
clearly placed the role of oversight 
regarding the quality of care on the 
board of the hospital. 
There was a veritable era of weeding 
out poor quality from 1965 to 1990; 
peer review systems were established 
and quality “assurance” programs 
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were created to begin identifying 
poor performing physicians in 
hospital settings. Additionally, in 
1984 Donabedian articulated 7 pillars 
of quality that health care providers 
must incorporate into their delivery 
systems: efficacy, efficiency, optimality, 
acceptability, legitimacy, equity, and cost. 
Although his paper was a breakthrough 
in thinking about improvement of 
health care quality, surprisingly few 
providers took on the challenge of 
developing a systematic approach to 
health care quality improvement. 
In 1999, the Institute of Medicine 
(IOM) published To Error is Human, 
which heightened awareness about 
human factors that influence health 
care delivery and articulated the rate 
of errors that occur in a health care 
delivery system. In 2001, the IOM 
issued a follow-up report, Crossing the 
Quality Chasm, which outlined the 
aims of medicine and affirmed that 
all health care should be safe, timely, 
effective, efficient, equitable, and 
patient-centered. Three years later, the 
National Quality Forum issued a ”call 
to responsibility” for health care boards 
to understand and accept their roles in 
providing oversight of the quality and 
safety of health care.
Provider organization governing boards 
must thoroughly comprehend this history 
to fulfill their fiduciary responsibility.
Transparency and Accountability 
Because fiduciary responsibility 
has expanded to include not only 
the financial health of the provider 
organization but also oversight of the 
quality of care it provides, boards must 
address the business case for improving 
quality. The substantial financial costs 
of poor quality include complications 
(eg, adverse drug events, hospital-
acquired infections) that may occur, 
adding significant costs to a patient’s 
episode of care. Governing boards must 
understand that financial improvements 
will result when health care providers 
practice with “standard work” and 
decreased practice variation. Improved 
outcomes and better patient experience 
lead to a more positive bottom line for 
health care organizations. 
Today there is increasing emphasis on 
transparency and accountability for the 
entire spectrum of health care delivery 
components. Health care organizations 
are expected to share data on the quality 
and safety of the care they provide and to 
assure that care is delivered in the most 
efficient manner. Calls for increased 
data transparency have led to health 
care organizations being measured on 
the quality, safety, and costs of care. 
Such data are now publicly available - 
yet another impetus for organizational 
transparency and accountability. 
Numerous national initiatives to 
promote the transparency of quality, 
safety, and costs have been implemented: 
•  In 2005, Medicare launched a pay-
for-performance demonstration 
program that was modified to 
create a “value-based purchasing” 
program in 2011. Health care 
organizations are now being paid 
for quality of care and patient 
experience scores. Financial 
penalties for poor care (eg, hospital 
complications) soon will be 
launched by Medicare. 
•  The Institute for Healthcare 
Improvement has rallied for 
and modeled the use of data 
transparency to leverage and 
transform quality and patient safety. 
•  The newest initiative from Medicare 
is the Partnership for Patients 
campaign to reduce both harm and 
avoidable rehospitalizations. 
These initiatives emphasize the 
urgency of and create the platform 
for early organizational adoption 
and integration that ultimately will 
help attain the desired results - 
improved quality and patient safety 
and lower costs. With additional 
insight, governing boards will begin 
to anticipate issues and continually 
incorporate quality, safety, and 
efficiency outcomes into the 
organization’s infrastructure and 
strategic goals. 
Defining Quality 
In order to judge the success of the 
organizations they serve, boards must 
understand how quality is defined and 
measured in the context of health care. 
Unfortunately, there is no universal 
agreement on a succinct definition of 
quality or on appropriate measures to 
help define health care quality. 
Most boards would agree that the purpose 
of health care is to decrease morbidity 
from disease processes and to improve the 
productivity of their community members 
through caring for the sick as well as 
preventing other illnesses.
A few definitions of quality are worth 
exploring. 
The IOM defines health care quality 
as ”the degree to which health services for 
individuals and populations increase the 
likelihood of desired health outcomes and 
are consistent with current professional 
knowledge.” This definition allows 
many providers to feel comfortable 
with the care they are providing, yet it 
lacks specific measures that could lead 
to actionable steps to improve health 
care quality. 
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Donabedian suggested that we think 
about health care quality in terms of 
3 components: structure, processes, 
and outcomes. This is a preferable 
approach, incorporating elements that 
are more actionable for health care 
organizations desiring to improve 
health care quality. Structure allows an 
organization to assure that it has the 
appropriate facilities and equipment 
to provide excellent care. Reliable 
processes reflect the organization’s ability 
to provide evidence-based medicine 
and to achieve the outcomes desired. 
And finally, outcomes are measured in 
terms of importance to the patient (eg, 
decreasing morbidity or mortality). 
 
Emerging definitions of health care 
quality focus on patient-centered 
definitions of quality. A patient-
centered definition allows an 
organization to look internally at 
the kind of care it provides. Patient-
centered care is care wherein: 
•  patients have access to care by 
multiple means; 
•  care is based on patient needs  
and values; 
•  patients are the source of control; 
•  there is shared knowledge and a 
free flow of information between 
providers and patients; 
•  decision making is evidence based 
and specific to the patient’s situation; 
•  safety is a fundamental attribute of 
the organization; 
•  care anticipates the patients’ needs. 
Finally, we must broaden our 
understanding of health care to 
encompass “value.” Boards need to 
have basic knowledge of how to define 
the value of the health care their 
organizations deliver to the populations 
they serve. In this era of health care 
reform, we are called on to appreciate 
the impact of health care on the 
population and the costs of care for 
our communities. With its focus on 
value, this contemporary definition of 
quality will certainly take boards in new 
directions as they consider their fiduciary 
responsibility and their approaches to 
organizational modeling and operations. 
The Board’s Connection 
Governing boards have a very significant 
role in defining and shaping the 
context in which services are delivered 
within the organization. The board 
oversees infrastructure such as facilities, 
medical staff, and the tools necessary 
for improvement. The board selects 
what processes will be in place, what 
services the organization will deliver, 
what departments exist, and what kind 
of procedures will be done. Importantly, 
the board has oversight over all of 
the outcomes the health care delivery 
system achieves; hence, measuring and 
improving these outcomes are a vital 
part of the board’s responsibility. 
The board must recognize and 
acknowledge its role and responsibility 
in ensuring quality of care by directing 
the creation of a culture of patient 
safety within the organization and 
supporting the efforts necessary 
to achieve clinical excellence. By 
becoming educated about the 
measures of health care quality and the 
improvement science that results from 
analysis of data, the board will improve 
its oversight of health care quality.
Levers of Governance 
To fulfill its responsibilities, the board 
can use certain levers of governance  
to help the organization achieve its  
goals: (1) Mission, (2) Culture,  
(3) Performance, (4) Leadership,  
(5) Strategy, and (6) Resource allocation.
1.  Mission. The hospital’s mission 
states the organization’s purpose 
and establishes the direction of its 
journey. Accountabilities generally 
fall into 3 categories for the mission: 
quality of care, access to care, and 
stewardship. The governing board 
has the ability to alter the mission 
to provide oversight of these 3 
major categories.
2.  Culture. The governing board has 
the responsibility to assure that the 
health care organization’s culture 
includes quality among its highest 
values and provides the ongoing 
resources and support necessary 
to fulfill its commitment to health 
care quality. The board must 
ensure a culture of improvement 
and a culture of patient safety 
throughout the organization.
3.  Performance. Boards must 
ensure that the organization 
commits to a definition of quality 
that addresses the needs of its 
stakeholders and that the definition 
is operationalized through 
performance measures that help its 
leaders evaluate the extent to which 
the commitment is being fulfilled.
4.  Leadership. The board must 
ensure that health care quality 
is understood by leadership 
at both the management and 
board levels. Finding the proper 
expertise for management and 
governance becomes the ultimate 
responsibility of the board.
5.  Strategy. Boards are obligated to 
ensure that the organization has 
strategies, goals, and performance 
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measures in place to foster 
performance that both enables and 
supports mission achievement. 
Because quality and patient safety are 
so critical to fulfilling the mission, 
the organization’s board has the 
responsibility to make sure there is a 
strategic plan to improve health care 
quality, patient safety, and the overall 
value of the health care delivered.
6.  Resource allocation. Boards 
often are faced with difficult 
decisions and trade-offs between 
cost, quality, competitiveness, 
and efficiency. Boards must pay 
special attention to the appropriate 
allocation of resources that will 
help to achieve high-quality and 
low-cost care. The board must stay 
focused on what is important for 
the delivery of health care and on 
the mission of the organization.
Tactics for Board Engagement in Quality 
Four tactics can help the board become 
engaged in health care quality: (1) 
increasing the quality literacy of the 
board, (2) creating an agenda for quality, 
(3) quality planning and focus, and (4) 
sharing patient-centered stories.
1.  Literacy. The board must become 
educated on salient issues regarding 
quality beyond those related to 
public reporting. A quality expert 
should sit on the board to help 
initiate and lead discussions about 
what defines health care quality. 
Board retreats offer opportunities 
for in-depth dialogue on quality 
and safety projects. Finally, board 
members should attend national 
health care conferences.
2.  Frame an agenda. The board chair 
and the chief executive officer 
should meet to discuss the status 
of quality in the organization. At 
every meeting, the board should 
hear how the hospital is progressing 
in terms of quality, what barriers 
exist to achieving breakthrough 
performance, and how the board can 
support improvement of health care 
quality. A discussion of quality on 
the board agenda at every meeting 
ensures that it will get equal billing 
with other important agenda items.
3.  Quality planning. The board should 
help create a vision for quality as 
part of the health care organization’s 
long-term measures and goals, 
such as target quality measures 
(eg, mortality, complications) and 
value-based purchasing measures. 
The board should review the 
organization’s quality plan for 
conformity with the overall strategic 
plan and should review appropriate 
quality measures on a regular basis.
4.  Patient-centeredness stories. 
Patients’ stories should be shared 
with the board at its meetings to 
further increase the focus on patient-
centeredness. Sharing patient 
stories ensures that the board stays 
focused on the processes and the 
barriers to improving the quality of 
care. Positive and negative stories 
highlight the importance of the 
many quality initiatives going on 
throughout the organization.
Tasks to Improve Quality 
There are 4 specific tasks involved in 
improving the quality of care:
1.  Establishing culture. Boards should 
ensure that management has an 
understanding of safety that includes 
training in systems thinking as 
well as in improvement science. 
Organizations that use human 
factors to help design processes 
have better results and better care. 
Board members can participate in 
promoting a culture of safety by 
walking around the organization 
with management, focusing in on 
errors, teamwork, and transparency 
so that everyone sees the goals of 
creating a culture of safety.
2.  Establishing performance goals. 
Boards must set specific performance 
goals for the organization. Some 
boards use the IOM aims (ie, safety, 
timeliness, effectiveness, efficiency, 
equity, patient-centeredness) to 
help decide upon measures for their 
organizations. Newer measures to 
evaluate the health care delivery 
system’s impact on improving 
population health, per capita costs, 
and patient experience also could 
be used. The data must be readily 
available and used on a regular 
basis to help drive improvement. 
Accountability for these performance 
goals must be incorporated into 
management’s responsibilities.
3.  Promoting leadership collaboration. 
Boards must ensure that 
management and physicians 
are collaborating to achieve 
improvements in quality, patient 
safety, and value. The medical 
staff must be engaged in health 
care quality and its leaders must 
be committed to establishing 
a culture of improvement and 
safety for the organization. These 
medical staff leaders must be able 
to work in a multidisciplinary 
fashion with management teams to 
create “standard work,” to decrease 
practice variation, and to improve 
health care quality.
4.  Empowering a Quality Committee
 Finally, the board should establish 
an independent governance 
committee to oversee quality of 
This newsletter was jointly developed and subject to editorial review by Jefferson School of Population Health and Lilly USA, LLC, and is supported through funding by Lilly USA, LLC. 
8 Prescriptions for Excellence in Health Care
care. The Quality Committee must 
be multidisciplinary, involving 
physicians, nurses, and board 
members as well as experts in 
improvement. Oversight of the 
Quality Committee includes 
performance improvement, clinical 
outcomes, patient satisfaction, and 
patient safety. Literacy in health 
care quality, patient experience, 
and measurement are required 
for members of the Quality 
Committee. The health care 
Quality Committee should demand 
total transparency throughout the 
organization and use performance 
data to help drive improvement.
Conclusions 
There are new levels of transparency and 
accountability in health care delivery 
today. Governing boards have a specific 
call to responsibility in providing oversight 
of the quality of care that the organization 
delivers. There are specific levers of 
governance that boards can use to help 
improve health care quality and there are 
specific tasks that a board can employ 
to improve the oversight of health care 
quality. As health care organizations move 
forward in the era of health care reform, 
understanding the value that health care 
organizations provide with regard to 
improving population health in a cost-
effective manner will become paramount 
to the role of governing boards.
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It is no secret that governing boards - 
including hospital and health systems 
boards - are under enormous pressure to 
become more accountable and effective. 
Good governance is a challenge for 
hospitals and health systems as they 
continue to transform themselves in 
response to these pressures. The role of 
the governing board is oftentimes unclear 
in this challenging environment. This 
article will examine 3 recent governance 
trends that can make a difference in 
building a better board: notably, (1) 
the movement toward “formal board 
education” programs, (2) the concept of 
director and board competencies, and 
(3) the increasing demand for board and 
director assessment. 
Board Education 
Today, everyone understands the value 
and importance of board education, 
especially in the exceedingly complex 
health care industry. However, the 
demand for “accountable governance” 
has driven many stakeholders and 
governing boards to go further by 
pursuing formal board education 
programs. By 2011, eleven state hospital 
associations had instituted some form 
of voluntary, formal board education 
program for hospital boards and 
directors. New Jersey passed legislation 
requiring that directors and trustees of 
hospital boards receive 7 hours of formal 
board education as a legal requirement 
and condition for serving on a hospital 
board. Since then, Delaware, Arkansas, 
and South Carolina state hospital 
associations have implemented formal 
board training programs for their 
hospital trustees and directors.
Why the trend toward formal board 
education? Some might argue that 
it provides a baseline for educational 
competency, demonstrating to 
stakeholders that the hospital’s directors 
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and boards have taken the time to 
complete formal training and education. 
Others might argue that a voluntary 
state hospital association initiative could 
possibly help to ward off potential 
legislation that would mandate it, as 
was the case in New Jersey. Finally, as 
the vast majority of hospital directors 
and trustees are volunteers who serve 
without compensation, it can be said 
that there are many who pursue such 
programs in the spirit of service. 
These programs are not without their 
critics. Many state associations appear 
to be opting out of formal certificate/
certification programs because they 
believe that the programs are not 
sufficiently rigorous or that they 
provide a false sense of competency 
and achievement. Clearly, health care 
governing boards need - and will continue 
to need - plenty of education, especially 
in light of the many upcoming changes 
to the payment delivery system. However, 
the jury is still out as to whether these 
state association initiatives will prove to 
be a definitive vehicle for establishing 
board educational competency, or 
whether they will need to do more.
The truth is that the educational needs 
of governing boards are not likely to 
be satisfied merely through certificate 
programs. Health care is complex, and 
each director and governing board 
is unique. Although these certificate 
programs arguably could provide some 
core training for boards, they need 
much more. 
Board education programs should be 
aligned with comprehensive board 
orientation programs. Such programs 
acquaint new directors not only with 
health care in general but also with the 
organization they will be governing, 
including market dynamics and 
upcoming changes in the delivery 
system (ie, health reform). Further, a 
recent governance report published by 
the Alliance for Advancing Nonprofit 
Healthcare suggested that governing 
boards conduct individual director 
educational assessments to target 
specific needs and opportunities 
to enhance board knowledge and 
performance through education. 
Competent and Qualified to Govern 
Another emerging issue is board 
competencies (ie, assessing whether 
governing boards and individual 
directors are competent and qualified 
to govern). In 2009, the American 
Hospital Association (AHA) Center for 
Healthcare Governance’s Blue Ribbon 
Report ultimately defined competency 
as the combination of knowledge, skills, 
personal characteristics, and individual 
social behaviors needed to effectively 
perform a job.
A closely related concept is whether 
a governing board is “qualified” to 
govern. In February 2010, the Securities 
Exchange Commission (SEC) issued 
a new series of regulations on director 
qualifications for publically traded 
companies. The SEC regulations require 
that corporations disclose to shareholders 
biographical information about directors 
and nominees so that shareholders may 
determine whether directors have the 
requisite qualifications to govern.
Although competency-based governance 
continues to gain acceptance as an 
important standard of governance, 
health care organizations have been 
slow to react. In fact, a 2011 AHA 
Center for Healthcare Governance 
report indicates that the vast majority 
of health care governing boards are 
not employing “competency-based” 
governance standards. Further, and 
perhaps more troubling, is that those 
health care organizations that do employ 
competency-based tools continue to rank 
finance and strategic visioning as the “top 
2” competencies—with patient safety 
and quality rating a distant fifth place.
In an age of increasing transparency, 
hospitals and health systems are well 
advised to take standards for board 
competencies and qualifications 
more seriously. Further, as health 
care migrates from fee for service to 
population health, hospitals and health 
systems would be well advised to gain 
substantial expertise in quality and 
safety as this will be the foundation for 
both payment and performance in our 
new value-based system of health care. 
Board and Director Evaluation  
and Assessment 
A final area of increasing importance is 
evaluation and assessment, particularly 
individual director assessment. 
Feedback is essential for both personal 
and professional growth and maturity. 
This is true for the governing board. A 
2010 Governance Institute study revealed 
that the vast majority of directors and 
chief executive officers believed that 
feedback about individual director 
performance would help improve 
governance and help build a better board. 
Yet, a 2011 AHA Center for Healthcare 
Governance survey indicated that most 
boards are far off the mark. Fewer than 
25% of those surveyed indicated that 
individual board members conducted 
self-assessments and that fewer than 3% 
conducted peer-to-peer assessments.
In this instance, there is wide disparity 
between what boards and directors 
think they should do to become better 
boards and what they actually do. This 
is not surprising as most hospital and 
health system directors and boards 
are volunteers, and those who are 
compensated receive fairly negligible 
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remuneration for the time they spend 
and the responsibilities they bear. Under 
these circumstances, some directors 
might find it disconcerting to have their 
behavior and performance evaluated by 
others, including their peers. However, 
this need not be the case.
Communication is at the heart of 
evaluation and assessment. The purpose 
of assessment is to strengthen the board 
by providing helpful, productive feedback 
that will not only build a better board but 
also will enable directors to maximize their 
capacity and potential to be contributing, 
effective board members. There are many 
tools and techniques that boards can 
employ to accomplish these goals without 
imputing a harsh, hypercritical evaluation 
technique. Further, if done properly, each 
director should be given the opportunity 
to comment on the board itself to help 
build a better, more effective board and to 
help keep directors involved, interested, 
and engaged.
Conclusion 
We are moving away from an era 
in which boards and directors were 
merely “presumptively qualified” 
by their resumes (ie, their training, 
education, experience) and moving 
toward a model of board accountability 
and effectiveness. Board education, 
competencies, and qualifications, and 
board and director assessment are 3 
areas that hospitals and health system 
governing boards can embrace to meet 
the challenges of changing systems of 
governance. The opportunity exists to 
build highly effective and accountable 
health care governing boards. 
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Accountable Care Organizations 
(ACOs) are at the heart of initiatives to 
reform health care delivery under the 
Affordable Care Act (ACA). ACOs are 
designed to move payment structures 
beyond the perverse incentives of “fee 
for service.” They build in rewards for 
delivering more efficient, high-quality 
care by creating accountability for a 
specific patient population and sharing 
in the savings derived from delivering 
care to that population.
Although some ACOs are fully 
integrated delivery systems governed 
by a single board, they were explicitly 
designed as a construct to bring together 
multiple corporate entities to function as 
an integrated system of care. This article 
focuses on the implications of this multi-
entity construct for board governance, and 
elaborates on the following propositions:
•  In bringing together multiple 
corporate entities to act as part of an 
integrated system, ACOs create an 
expanded role for governance. 
•  The dual demands on ACOs 
for both cost and quality create a 
strengthened imperative for effective 
board oversight of care quality.
•  To succeed, ACO boards will 
need to embrace responsibility 
for developing and overseeing an 
aligned, high-commitment, high-
trust system of care for patients.
Multi-entity ACOs Expand the Role of  
Board Governance 
ACOs create a formal legal structure 
that enables “shared governance” 
so that multiple corporate entities 
function as a coordinated system that 
is accountable for the care delivered 
to a population of patients and that 
provides a mechanism to receive and 
distribute payments for shared savings. 
Historically, there have been various 
legal barriers to coordination across 
independent provider entities. 
Implementation of the ACA explicitly 
sought to address these; for example, 
providing ACOs with waivers of the 
application of the Physician Self-
Referral Law, the Federal antikickback 
statute, and applying a “rule of 
reason” antitrust test (rather than 
per se illegality) for price setting and 
market allocation agreements among 
competing providers who participate 
in an ACO, including explicit support 
for risk-sharing arrangements that 
promote efficiency. 
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With these barriers removed, the 
challenge for ACOs is to develop an 
organizing approach that achieves 
effective coordination and integration 
across entities to optimize patient 
outcomes. To the extent that multiple 
institutions are involved, each with 
its own governing board, the required 
integration of decision making and 
cross-boundary coordination cannot rely 
on a single hierarchical line of authority, 
because the line of accountability 
within each institution runs from its 
administrative and clinical leadership 
to its own board. Instead, achieving 
effective coordination and integration 
depends on an expanded governance 
role for the ACO board. Specifically, 
the accountability of constituent entity 
boards to the ACO board serves as the 
basis for the administrative and clinical 
leadership of the ACO to provide 
direction to the enterprise. Figure 1 
illustrates how the authority of ACO 
leadership is derived from that of the 
ACO board in a multi-entity structure. 
Dual ACO Responsibility for Cost and 
Quality Creates a Strengthened Imperative 
for Effective Quality Oversight  
Although enhancing the effectiveness 
of board oversight of the quality and 
safety of patient care has been a major 
focus in health care for nearly a decade, 
the imperative for ACO boards is 
even greater. With powerful incentives 
to reduce costs, ACOs will be under 
heightened scrutiny from patients 
and other observers for any signs that 
they are sacrificing quality to cut costs. 
Indeed, the ACA invited such scrutiny 
by including stringent requirements 
around transparency of ACO 
performance on both quality and patient 
satisfaction dimensions.
In particular, ACOs must overcome the 
legacy from our earlier experience with 
health maintenance organizations. As 
the Department of Health and Human 
Services noted in promulgating the 
final rule implementing ACOs under 
the ACA, “Many commenters were 
concerned that the Shared Savings 
Program has similar characteristics to 
some forms of managed care where it 
is possible to achieve savings through 
inappropriate reductions in patient care.” 
It follows that ACO boards must 
understand that ensuring unimpeachable 
quality and safety of patient care is 
central to their institutional mission 
and viability, and is necessary to ensure 
patient confidence in the integrity of the 
ACO’s clinical decision making. 
Board Governance Role in Ensuring High-
Trust, High-Commitment Systems of Care 
In addition to a strong focus on quality, 
a multi-entity ACO board must 
play an expanded role in overseeing 
the effectiveness of the care delivery 
system, ensuring:
•  An effective system design and 
corresponding funds flows to align 
incentives around providing high-
quality, cost-effective care.
•  A shared culture and commitment 
to a common purpose of effective 
patient care that enables effective 
cross-boundary collaboration. 
System Design to Align Incentives 
The board has ultimate responsibility 
for the design of the system of care, so 
as to enable and reinforce appropriate 
patient referral flows and clinical 
decision making. Key elements include 
the effective design of accountability 
units and their corresponding funds flow 
to provide incentives to optimize “Triple 
Aim” outcomes.
Board focus on system design is 
particularly important because of the 
fundamental shifts in relative bargaining 
power that the move to a patient 
Figure 1.  ACO Board Authority Sets the Context for Effective Executive Leadership  
in Multi-Entity Systems
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population perspective is likely to set in 
motion. Patient care likely will become 
more primary care centered, with funds 
flow models that increasingly treat the 
primary care practice as accountable for 
”Triple Aim” outcomes for it’s patients 
and, specifically, total medical expense. 
Conceptually, primary care will become 
the purchaser of services from specialty, 
hospital, and ancillary services. To the 
extent this occurs, it will put significant 
pressure on specialists, who become 
cost centers rather than profit centers, 
and on shifting care out of higher cost 
tertiary institutions into more cost-
effective community hospitals. 
The ACO board may well be 
confronted by constituent entities 
that are more focused on protecting 
legacy positions and assets than on 
the optimal design for the future, and 
will need to be actively involved in 
negotiating a viable path.
Culture and Commitment to the Purpose 
of Patient Care  
In addition to ensuring aligned 
accountabilities and financial incentives 
for effective system functioning, ACO 
boards also will need to focus attention 
on promoting a shared culture and 
mind-set among system participants 
to enable effective collaboration across 
entity boundaries. 
ACO Boards will need to appreciate that 
the enterprise is both an economic entity 
and a social institution in which individual 
providers’ sense of affiliation and 
commitment is shaped by the extent to 
which they believe there is a meaningful 
common purpose and a community of 
colleagues with whom they identify. 
Multi-entity ACOs represent an attempt 
to gain the benefits of functioning as an 
integrated system without moving to 
full asset merger. The paradox for these 
ACOs is that what they are trying to do 
is harder than functioning within a single 
system; therefore, they must work harder 
on mind-set, trust, and commitment – 
starting with the ACO board. 
 Whether multi-entity ACOs represent an 
approach that is viable over the long run, 
or simply a transitional stage to greater 
consolidation of integrated systems, will 
depend heavily on how effectively ACO 
boards are able to address the governance 
challenges highlighted in this article.
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